top of page
BPIQ Blog
Aug 7, 20231 min read
SYFOVRE (APLS) vs. IZERVAY (Astellas)
Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...
Jul 31, 20231 min read
Apellis Pharmaceuticals (APLS)
BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...
Aug 24, 20221 min read
Biopharma Daily Pulse - 08/24/22
$XBI $89.63 | +2.11% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Aug 24, 20221 min read
Free Biopharma Daily Pulse - 08/24/22
$XBI $89.63 | +2.11% Table of Contents: Top 10 Daily Positive Movers Top 10 Daily Negative Movers Top 10 Daily Volume Movers Want to...
Jul 27, 20221 min read
Biopharma Mid Morning Pulse - 07/27/22
(Posted 10:05am CST) $XBI $81.35 | +0.06% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 27, 20221 min read
Free Biopharma Mid Morning Pulse - 07/27/22
(Posted 10:05am CST) $XBI $81.35 | +0.06% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 19, 20221 min read
Biopharma Mid Morning Pulse - 07/19/22
(Posted 9:45am CST) $XBI $82.63 | +3.62% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 19, 20221 min read
Free Biopharma Mid Morning Pulse - 07/19/22
(Posted 9:45am CST) $XBI $82.63 | +3.62% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 14, 20221 min read
Biopharma Mid Morning Pulse - 07/14/22
(Posted 10:30am CST) $XBI $81.43 | -2.17% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jul 14, 20221 min read
Free Biopharma Mid Morning Pulse - 07/14/22
(Posted 10:30am CST) $XBI $81.43 | -2.17% Table of Contents: Top 10 AM Positive Movers Top 10 AM Negative Movers Top 10 AM Volume Movers...
Jun 10, 20223 min read
Biopharma Daily Stock Updates - 06/10/22
$XBI $67.03 | -4.60% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #GRTS -0.4% Gritstone Announces...
Jun 10, 20223 min read
Free Biopharma Daily Stock Updates - 06/10/22
$XBI $67.03 | -4.60% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #GRTS -0.4% Gritstone Announces...
Jun 8, 20225 min read
EHA 2022 (European Hematology Association) - Annual Meeting
Summary: The European Hematology Association Annual 2022 Meeting is taking place from June 9-12, 2022 virtually and in-person in Vienna,...
Jun 7, 20222 min read
Biopharma Daily Stock Updates - 06/07/22
$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...
Jun 7, 20222 min read
Free Biopharma Daily Stock Updates - 06/07/22
$XBI $72.60 | +4.94% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX 0.0% (+22% AH) Novavax...
Jun 1, 20223 min read
Biopharma Daily Stock Updates - 06/01/22
$XBI $67.53 | -1.8% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #COCP +2.7% Cocrystal Pharma...
Jun 1, 20223 min read
Free Biopharma Daily Stock Updates - 06/01/22
$XBI $67.53 | -1.8% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #COCP +2.7% Cocrystal Pharma...
May 19, 20221 min read
Q1 2022 Orbimed Biotech Hedge Fund Update
At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...
May 19, 20221 min read
Q1 2022 Perceptive Biotech Hedge Fund Update
At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...
May 16, 20222 min read
Q1 2022 EcoR1 Biotech Hedge Fund Update
At BPIQ we have started to track quarterly 13F filings for some of the largest biotech hedge funds. Q1 2022 13F filings were made on or...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page